Agf Investments LLC Moderna, Inc. Transaction History

Agf Investments LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$126.46 - $235.05 $356,111 - $661,900	-2,816 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$225.82 - $368.51 $635,909 - $1.04 Million	2,816 New	2,816 $715,000
Q3 2021 Nov 10, 2021	SELL	$221.9 - $484.47 $803,499 - $1.75 Million	-3,621 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$129.91 - $234.98 $66,384 - $120,074	-511 Reduced 12.37%	3,621 $851,000
Q1 2021 May 14, 2021	SELL	$109.18 - $185.98 $413,027 - $703,562	-3,783 Reduced 47.8%	4,132 $541,000

Q4 2020 Feb 08, 2021	SELL	$65.74 - $169.86 $774,351 - $2 Million	-11,779 Reduced 59.81%	7,915 $827,000
Q3 2020 Nov 12, 2020	SELL	$54.34 - $94.85 $89,497 - $156,217	-1,647 Reduced 7.72%	19,694 $1.39 Million
Q2 2020 Aug 11, 2020	BUY	$29.67 - $80.0 $633,187 - $1.71 Million	21,341 New	21,341 $1.37 Million

1,037

245M

12.1M

9.36M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $45.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Agf Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Agf Investments LLC with notifications on news.